A new patch for pain is available

Filed in archive Treatment on July 26, 2005

The FDA approved a combination lidocaine/tetracaine patch to be marketed as Synera:

ZARS, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Synera(TM), a topical local anesthetic patch, developed under the name of S-Caine(TM) Patch (lidocaine 70 mg and tetracaine 70 mg). This is ZARS' first product to be approved by the FDA.

The patch will be used to numb the skin before various medical procedures such as superficial venous access as well as certain dermatological procedures. The product is indicated for use in children and adults and will soon be for sale in the U.S.

Synera has a thin layer of a local anesthetic formulation integrated with an oxygen-activated heating element. The heating element enhances the delivery of the local anesthetics into the skin. When removed from its storage pouch, the patch begins to heat, warming the skin after application.

Read more about it here. ("ZARS pharma Announces FDA Approval of Synera(TM) Topical Local Anesthetic Patch", Yahoo! News, Jul.26)